{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T04:48:35Z","timestamp":1788929315117,"version":"build-2803163510"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"vor","delay-in-days":28,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016545","name":"Roche Diagnostics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016545","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002402","name":"Sun Yat-sen University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002402","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.diabres.2025.113068","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T07:42:39Z","timestamp":1766389359000},"page":"113068","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Economic evaluation of NT-proBNP for heart failure risk assessment in patients with type 2 diabetes in China"],"prefix":"10.1016","volume":"231","author":[{"given":"Miao","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1335-4006","authenticated-orcid":false,"given":"Zhiwei","family":"Leng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinguo","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junping","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaogui","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Powei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianwei","family":"Xuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2025.113068_b0005","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s13300-022-01243-x","article-title":"The prevalence of cardiovascular disease in adults with type 2 diabetes in China: results from the cross-sectional CAPTURE study","volume":"13","author":"Hong","year":"2022","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.diabres.2025.113068_b0010","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.3390\/biomedicines12071572","article-title":"Diabetes and heart failure: a literature review, reflection and outlook","volume":"12","author":"Li","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.diabres.2025.113068_b0015","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.jacc.2019.12.063","article-title":"Effects of liraglutide on cardiovascular outcomes in patients with diabetes with or without heart failure","volume":"75","author":"Marso","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.diabres.2025.113068_b0020","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.jval.2017.12.019","article-title":"Economic burden of cardiovascular disease in type 2 diabetes: a systematic review","volume":"21","author":"Einarson","year":"2018","journal-title":"Value Health"},{"key":"10.1016\/j.diabres.2025.113068_b0025","unstructured":"Chinese Society of Cardiology, Chinese Medical Association, Chinese College of Cardiovascular Physician, Chinese Heart Failure Association of Chinese Medical Doctor Association, Editorial Board of Chinese Journal of Cardiology. [Chinese guidelines for the diagnosis and treatment of heart failure 2024]. Zhonghua Xin Xue Guan Bing Za Zhi. 2024;52:235-75. doi: 10.3760\/cma.j.cn112148-20231101-00405."},{"key":"10.1016\/j.diabres.2025.113068_b0030","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.jacc.2013.05.069","article-title":"PONTIAC (NT-proBNP selected prevention of cardiac events in a population of diabetic patients without a history of cardiac disease): a prospective randomized controlled trial","volume":"62","author":"Huelsmann","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.diabres.2025.113068_b0035","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12933-021-01221-w","article-title":"Performance of the recommended ESC\/EASD cardiovascular risk stratification model in comparison to SCORE and NT-proBNP as a single biomarker for risk prediction in type 2 diabetes mellitus","volume":"20","author":"Prausm\u00fcller","year":"2021","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.diabres.2025.113068_b0040","first-page":"e895","article-title":"2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.diabres.2025.113068_b0045","first-page":"16","article-title":"Guideline for the prevention and treatment of diabetes mellitus in China (2024 edition)","volume":"17","author":"Chinese Diabetes Society","year":"2025","journal-title":"Chin J Diab Mellit"},{"key":"10.1016\/j.diabres.2025.113068_b0050","first-page":"1017","article-title":"Chinese expert consensus on risk assessment and management of pan-vascular disease in patients with type 2 diabetes (2022 edition)","volume":"14","author":"Chinese College of Cardiovascular Physicians","year":"2022","journal-title":"Chin J Diab"},{"key":"10.1016\/j.diabres.2025.113068_b0055","doi-asserted-by":"crossref","unstructured":"American Diabetes Association Professional Practice Committee. 10. Cardiovascular disease and risk management: standards of care in diabetes-2025. Diabetes Care. 2025;48:S207\u2013s38. doi: 10.2337\/dc25-S010.","DOI":"10.2337\/dc25-S010"},{"key":"10.1016\/j.diabres.2025.113068_b0060","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1080\/13696998.2023.2264722","article-title":"Cost-effectiveness of NT-proBNP-supported screening of chronic heart failure in patients with or without type 2 diabetes in Austria and Switzerland","volume":"26","author":"Walter","year":"2023","journal-title":"J Med Econ"},{"key":"10.1016\/j.diabres.2025.113068_b0065","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jval.2021.11.1351","article-title":"Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations","volume":"25","author":"Husereau","year":"2022","journal-title":"Value Health"},{"key":"10.1016\/j.diabres.2025.113068_b0070","first-page":"968","article-title":"Cardiovascular disease risk in diabetes patients aged 40 years old and above in China","volume":"48","author":"Li","year":"2020","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"10.1016\/j.diabres.2025.113068_b0075","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1161\/CIRCULATIONAHA.116.022367","article-title":"Predicting the 10-year risks of atherosclerotic cardiovascular disease in Chinese population: the China-PAR Project (Prediction for ASCVD Risk in China)","volume":"134","author":"Yang","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.diabres.2025.113068_b0080","first-page":"315","article-title":"Guideline for the prevention and treatment of type 2 diabetes mellitus in China (2020 edition)","volume":"13","author":"Chinese Diabetes Society","year":"2021","journal-title":"Chin J Diab Mellit"},{"key":"10.1016\/j.diabres.2025.113068_b0085","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1093\/eurheartj\/ehad192","article-title":"2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes","volume":"44","author":"Marx","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.diabres.2025.113068_b0090","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/j.jcmg.2018.03.015","article-title":"Diagnosis of nonischemic stage B heart failure in type 2 diabetes mellitus: optimal parameters for prediction of heart failure","volume":"11","author":"Wang","year":"2018","journal-title":"J Am Coll Cardiol Img"},{"key":"10.1016\/j.diabres.2025.113068_b0095","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jchf.2020.10.013","article-title":"Biomarker-based risk prediction of incident heart failure in pre-diabetes and diabetes","volume":"9","author":"Pandey","year":"2021","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.diabres.2025.113068_b0100","first-page":"440","article-title":"Effects of sodium-glucose cotransporter 2 inhibitors on cardiovascular outcomes in elderly patients with comorbid coronary heart disease and diabetes mellitus","volume":"18","author":"Xu","year":"2021","journal-title":"J Geriatr Cardiol"},{"key":"10.1016\/j.diabres.2025.113068_b0105","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.121.009218","article-title":"Development of advanced heart failure: a population-based study","volume":"15","author":"Subramaniam","year":"2022","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.diabres.2025.113068_b0110","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.jchf.2021.05.009","article-title":"Advanced heart failure epidemiology and outcomes: a population-based study","volume":"9","author":"Dunlay","year":"2021","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.diabres.2025.113068_b0115","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1186\/s12889-023-17286-z","article-title":"Sex difference in incidence and risk factors of hospitalization for heart failure, and subsequent mortality: findings from the China PEACE Million Persons Project","volume":"23","author":"Qiu","year":"2023","journal-title":"BMC Public Health"},{"key":"10.1016\/j.diabres.2025.113068_b0120","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1001\/jama.2016.19720","article-title":"Association between diabetes and cause-specific mortality in rural and urban areas of China","volume":"317","author":"Bragg","year":"2017","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.diabres.2025.113068_b0125","article-title":"Factors associated with the incidence and the expenditure of self-medication among middle-aged and older adults in China: a cross-sectional study","volume":"11","author":"Liu","year":"2023","journal-title":"Front Public Health"},{"key":"10.1016\/j.diabres.2025.113068_b0130","first-page":"52","article-title":"Investigation and analysis of influencing factors of hospitalization costs of heart failure patients in first-tier cities in China","author":"Xuan","year":"2017","journal-title":"China Health Insurance"},{"key":"10.1016\/j.diabres.2025.113068_b0135","first-page":"61","article-title":"Study on indirect medical costs and quality of life of heart failure patients in China in the real world","author":"Xuan","year":"2017","journal-title":"China Health Insurance"},{"key":"10.1016\/j.diabres.2025.113068_b0140","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.121.008406","article-title":"Prevalence and incidence of heart failure among urban patients in China: a national population-based analysis","volume":"14","author":"Wang","year":"2021","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.diabres.2025.113068_b0145","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1111\/jch.14870","article-title":"The prevalence of monotherapy and combination therapy in hypertension in China from 2019 to 2021: a nationwide population-based cross-sectional study","volume":"26","author":"Luo","year":"2024","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.diabres.2025.113068_b0150","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1016\/S0140-6736(17)32476-5","article-title":"Availability, cost, and prescription patterns of antihypertensive medications in primary health care in China: a nationwide cross-sectional survey","volume":"390","author":"Su","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.diabres.2025.113068_b0155","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00592-020-01618-1","article-title":"Health utility of type 2 diabetes patients using basal insulin in China: results from the BEYOND II study","volume":"58","author":"Li","year":"2021","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.diabres.2025.113068_b0160","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1136\/heartjnl-2013-304598","article-title":"The cost effectiveness of ivabradine in the treatment of chronic heart failure from the U.K. National Health Service perspective","volume":"100","author":"Griffiths","year":"2014","journal-title":"Heart"},{"key":"10.1016\/j.diabres.2025.113068_b0165","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.2337\/dci22-0014","article-title":"Heart failure: an underappreciated complication of diabetes. a consensus report of the American Diabetes Association","volume":"45","author":"Pop-Busui","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2025.113068_b0170","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.diabet.2018.01.012","article-title":"Relation between HbA(1c) and incident cardiovascular disease over a period of 6 years in the Hong Kong population","volume":"44","author":"Wan","year":"2018","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.diabres.2025.113068_b0175","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1056\/NEJMoa1800256","article-title":"Risk factors, mortality, and cardiovascular outcomes in patients with type 2 diabetes","volume":"379","author":"Rawshani","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2025.113068_b0180","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1002\/ehf2.14487","article-title":"Impact of age on characteristics, performance measures and outcomes of inpatients for heart failure in Beijing, China","volume":"10","author":"Yuan","year":"2023","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.diabres.2025.113068_b0185","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/ehf2.14184","article-title":"Clinical performance and quality measures for heart failure management in China: the China-Heart Failure registry study","volume":"10","author":"Zhang","year":"2023","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.diabres.2025.113068_b0190","unstructured":"National Bureau of Statistics of China. [Notice on conducting the Seventh National Population Census (State Council Document No. 24)], https:\/\/www.stats.gov.cn\/english\/PressRelease\/202105\/t20210510_1817185.html; 2021 [accessed 28 July 2025]."},{"key":"10.1016\/j.diabres.2025.113068_b0195","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","article-title":"EuroQol\u2013a new facility for the measurement of health-related quality of life","volume":"16","author":"EuroQol Group","year":"1990","journal-title":"Health Policy"},{"key":"10.1016\/j.diabres.2025.113068_b0200","series-title":"China guidelines for pharmacoeconomic evaluations 2020","author":"Liu","year":"2020"},{"key":"10.1016\/j.diabres.2025.113068_b0205","unstructured":"National Healthcare Security Administration. [Notice on carrying out the standardized management of medical service prices (first batch)\u201d, October 17, 2024, Medical Insurance Price Procurement Letter [2024] No. 217], 2024 [accessed 28 July 2025]."},{"key":"10.1016\/j.diabres.2025.113068_b0210","unstructured":"CPC Central Committee and the State Council. [\u201cHealthy China 2030\u201d Planning Outline], https:\/\/www.gov.cn\/zhengce\/2016-10\/25\/content_5124174.htm; 2016 [accessed 28 July 2025]."},{"key":"10.1016\/j.diabres.2025.113068_b0215","unstructured":"General Office of the State Council. [Notice of the General Office of the State Council on issuing China's medium- and long-term plan for the prevention and treatment of chronic diseases (2017-2025)], https:\/\/www.gov.cn\/zhengce\/content\/2017-02\/14\/content_5167886.htm; 2017 [accessed 28 July 2025]."}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822725010836?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822725010836?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T14:17:56Z","timestamp":1769696276000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822725010836"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":43,"alternative-id":["S0168822725010836"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2025.113068","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Economic evaluation of NT-proBNP for heart failure risk assessment in patients with type 2 diabetes in China","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2025.113068","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"113068"}}